B, Y., RN, S., CS, S., KB, H., CD, M., G, S., . . . KS, A. (2025). Triazolyl-indolo-quinoxaline triggers differential cell death pathways in pancreatic cancer via ROS/p38 axis. Chemico-biological interactions, 420, 111668. https://doi.org/10.1016/j.cbi.2025.111668
Chicago Style (17th ed.) CitationB, Yoon, Suresh RN, Shivakumara CS, Harsha KB, Mohan CD, Sethi G, Rangappa KS, and Ahn KS. "Triazolyl-indolo-quinoxaline Triggers Differential Cell Death Pathways in Pancreatic Cancer via ROS/p38 Axis." Chemico-biological Interactions 420 (2025): 111668. https://doi.org/10.1016/j.cbi.2025.111668.
MLA (9th ed.) CitationB, Yoon, et al. "Triazolyl-indolo-quinoxaline Triggers Differential Cell Death Pathways in Pancreatic Cancer via ROS/p38 Axis." Chemico-biological Interactions, vol. 420, 2025, p. 111668, https://doi.org/10.1016/j.cbi.2025.111668.